Novartis/Titan Iloperidone Deal In Doubt In Light Of QTc Prolongation Data
Titan Pharmaceuticals is likely to seek a new partner for iloperidone if Novartis decides to return rights to the schizophrenia drug
Titan Pharmaceuticals is likely to seek a new partner for iloperidone if Novartis decides to return rights to the schizophrenia drug